
1/10 We’re excited to announce the publication of our work with @StanfordMed, examining the premature deaths that would be saved if PRS-guided screening was introduced across seven common disease screening programs nature.com/articles/s41467-0…

Transforming health, healthcare and drug discovery through the power of genomics

1/10 We’re excited to announce the publication of our work with @StanfordMed, examining the premature deaths that would be saved if PRS-guided screening was introduced across seven common disease screening programs nature.com/articles/s41467-0…

At #LondonLifeSciencesWeek #JefferiesHealthcare, we’ve just announced a >$220 million extension of our strategic drug discovery collaboration with @VertexPharma. genomics.com/newsroom/genomi…

Read his quote on the DeepMind website here: deepmind.google/blog/alphage…

Our CEO @genemodeller's view on @GoogleDeepMind AlphaGenome 2 launch: genomics.com/newsroom/alphag…

Don't miss our posters and presentations at the American Society of Human Genetics 2026! #ASHG2026

Listen: Genomics named Business of the Year 2026 @BBCRadio4. We were nominated by business leaders including Deputy President of @techUK following @genemodeller President's Award win for the Economy bbc.co.uk/sounds/play/m002z7…


Watch: Our CEO Professor Sir Peter Donnelly's interview for @techUK President's Awards 2026. Following this, Genomics was named Business of the Year 2026 by @BBCRadio4 - listen and watch below, links in thread! #techUK #PresidentsAwards #Genomics #tech #BBC #TheBottomLine #Health


We're heading to @HLTHEVENT in Amsterdam - you can find us on the Main Stage and on the Pharma Summit stage this Wednesday! 🚀 #HLTHEurope

Our CEO and Co-Founder Prof Sir @genemodeller had the honour of pitching at the OFI VC Health Tech Showcase, hosted by the @GOVUK @UKinvestoffice in partnership with @LSEplc #TechBio #HealthTech #Biotech #Genomics #OFI #LondonStockExchange #Investment #LifeSciences

The East Coast US Launch of #MystraAI took place at #FOGBoston this afternoon! ✨Our VP of Life Sciences, Alexandra Fish's talk was entitled: 'Causal by design: genetics-first discovery combined with agentic AI as the engine of next-generation therapeutics'.

Can AI make drug discovery faster, safer and more successful? UK TechBio company @Genomicsltd has launched Mystra AI, an agentic platform using large-scale human genetics data to help identify and validate drug targets. A sign of how the UK is combining genomics, AI and life sciences to shape the future of medicine. politicsuk.com/news/techbio-…


Bringing a new drug to market costs $2.3bln. 95% of drug candidates fail. But what if we could fundamentally change this? At #SXSWLondon, we launched #MystraAI - the definitive solution for genetics-based drug target discovery. 🚀#AI #Pharma #Biotech #DrugDiscovery

Our VP of Life Sciences, Alexandra Fish, is a keynote speaker today - 12:00 PM local time - at #FOGBoston. Find her on the AI in Drug Discovery Stage and find out more about Mystra AI! You can find our team on Booth 6. See you there! #FOG